Scott Eggener
Scott Eggener
Associate Professor of Surgery (Urologic Oncology), University of Chicago
Verified email at
Cited by
Cited by
MRI-targeted or standard biopsy for prostate-cancer diagnosis
V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ...
New England Journal of Medicine 378 (19), 1767-1777, 2018
Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies
SD Kundu, KA Roehl, SE Eggener, JAV Antenor, M Han, WJ Catalona
The Journal of urology 172 (6 Part 1), 2227-2231, 2004
Active surveillance for prostate cancer: a systematic review of the literature
MA Dall’Era, PC Albertsen, C Bangma, PR Carroll, HB Carter, ...
European urology 62 (6), 976-983, 2012
Predicting 15-year prostate cancer specific mortality after radical prostatectomy
SE Eggener, PT Scardino, PC Walsh, M Han, AW Partin, BJ Trock, Z Feng, ...
The Journal of urology 185 (3), 869-875, 2011
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group
CM Moore, V Kasivisvanathan, S Eggener, M Emberton, JJ Fütterer, ...
European urology 64 (4), 544-552, 2013
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities
SE Eggener, PT Scardino, PR Carroll, MJ Zelefsky, O Sartor, H Hricak, ...
The Journal of urology 178 (6), 2260-2267, 2007
The role of SPINK1 in ETS rearrangement-negative prostate cancers
SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ...
Cancer cell 13 (6), 519-528, 2008
Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance
RK Berglund, TA Masterson, KC Vora, SE Eggener, JA Eastham, ...
The Journal of urology 180 (5), 1964-1968, 2008
Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR
AB Rosenkrantz, S Verma, P Choyke, SC Eberhardt, SE Eggener, ...
The Journal of urology 196 (6), 1613-1618, 2016
Positive surgical margins at partial nephrectomy: predictors and oncological outcomes
O Yossepowitch, RH Thompson, BC Leibovich, SE Eggener, JA Pettus, ...
The Journal of urology 179 (6), 2158-2163, 2008
Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis
A Oto, C Yang, A Kayhan, M Tretiakova, T Antic, C Schmid-Tannwald, ...
American Journal of Roentgenology 197 (6), 1382-1390, 2011
Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans.
NM Dietz, JM Rivera, SE Eggener, RT Fix, DO Warner, MJ Joyner
The Journal of physiology 480 (2), 361-368, 1994
Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence
SE Eggener, O Yossepowitch, JA Pettus, ME Snyder, RJ Motzer, P Russo
Journal of clinical oncology 24 (19), 3101-3106, 2006
Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score—a computer-aided …
Y Peng, Y Jiang, C Yang, JB Brown, T Antic, I Sethi, C Schmid-Tannwald, ...
Radiology 267 (3), 787-796, 2013
Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods
O Yossepowitch, SE Eggener, FJ Bianco, BS Carver, A Serio, ...
The Journal of urology 178 (2), 493-499, 2007
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma
JC Brien, SF Shariat, MP Herman, CK Ng, DS Scherr, B Scoll, RG Uzzo, ...
The Journal of urology 184 (1), 69-73, 2010
New and established technology in focal ablation of the prostate: a systematic review
M Valerio, Y Cerantola, SE Eggener, H Lepor, TJ Polascik, A Villers, ...
European urology 71 (1), 17-34, 2017
Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons
KC Zorn, G Gautam, AL Shalhav, RV Clayman, TE Ahlering, DM Albala, ...
The Journal of urology 182 (3), 1126-1132, 2009
Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy
O Yossepowitch, SE Eggener, AM Serio, BS Carver, FJ Bianco Jr, ...
European urology 53 (5), 950-959, 2008
Increasing incidence of metastatic prostate cancer in the United States (2004–2013)
AB Weiner, RS Matulewicz, SE Eggener, EM Schaeffer
Prostate cancer and prostatic diseases 19 (4), 395-397, 2016
The system can't perform the operation now. Try again later.
Articles 1–20